<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05116033</url>
  </required_header>
  <id_info>
    <org_study_id>VOTIAAFITP</org_study_id>
    <nct_id>NCT05116033</nct_id>
  </id_info>
  <brief_title>Value of Platelet Indices as Predictive Factor in Thrombocytopenia</brief_title>
  <official_title>Value of the Platelet Indices as a Predictive Factor in Adult Thrombocytopenic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Platelets are essential blood component involved in primary hemostasis. A platelet count of&#xD;
      less than 150 × 109/L is considered to be thrombocytopenia The causes of thrombocytopenia can&#xD;
      be divided into two major groups, a decreased production of platelets or an under&#xD;
      proliferative BM and an over-destruction of platelets. Under proliferative BM defects most&#xD;
      common cause is aplastic anemia, On the contrary, peripheral destruction of platelets may be&#xD;
      as a result of an immune-mediated process namely immune thrombocytopenia (ITP)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ITP is a common auto-immune disease in which platelet count is reduced in peripheral blood&#xD;
      leading to petechiae and hemorrhage. The platelet count is decreased because there are&#xD;
      auto-antibodies in circulation against platelets that bind to platelets surface and destroy&#xD;
      them in the spleen . Aplastic anemia is characterized by suppression of bone marrow function&#xD;
      resulting in progressive pancytopenia. The hematology analyzers can now give us certain&#xD;
      parameters that can give information about platelets. These parameters are referred to as&#xD;
      platelet indices in literature. Platelet indices include mean platelet volume (MPV), platelet&#xD;
      distribution width (PDW) and platelet large cell ratio (P-LCR) . They are sensitive,&#xD;
      non-invasive, inexpensive biomarkers. MPV is the most commonly investigated platelet&#xD;
      parameter, signifies the average size of platelets in the blood. PDW is a marker of platelet&#xD;
      anisocytosis, which describes distribution of platelets produced by megakaryocytes and&#xD;
      increases upon platelet activation. P-LCR is another marker of platelet activity, is a&#xD;
      percentage of all platelets with a volume measuring over 12 fl circulating in the bloodstream&#xD;
      .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 20, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the prognostic predictive value of the platelet indices in thrombocytopenic patients.</measure>
    <time_frame>6months</time_frame>
    <description>• Exploring the validity of platelets indices as prognostic biomarkers in thrombocytopenic patients.</description>
  </primary_outcome>
  <enrollment type="Anticipated">98</enrollment>
  <condition>Main Focus of the Study</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Participants of the study will be confirmed as thrombocytopenic patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age more than 18 years old regardless of gender.&#xD;
&#xD;
          -  Platelet count below 100000/cu mm.&#xD;
&#xD;
          -  Confirmed diagnosis aplastic anaemia.&#xD;
&#xD;
          -  Confirmed diagnosis immune thrombocytopenia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient who received a platelet or blood transfusion within two weeks prior MPV&#xD;
             analysis.&#xD;
&#xD;
          -  Splenectomized patients&#xD;
&#xD;
          -  Patients with chronic infection or inflammations.&#xD;
&#xD;
          -  Diabetics and patients with coronary artery disease.&#xD;
&#xD;
          -  Patients on anti- platelet or anti-inflammatory drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Dalia G mahran, prof.dr</last_name>
    <phone>01007120821</phone>
    <email>daliagm2001@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>safaa A ahmed</last_name>
    <phone>01064170058</phone>
    <email>safaakhaled2003@gmail.com</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Negash M, Tsegaye A, G/Medhin A. Diagnostic predictive value of platelet indices for discriminating hypo productive versus immune thrombocytopenia purpura in patients attending a tertiary care teaching hospital in Addis Ababa, Ethiopia. BMC Hematol. 2016 Jul 1;16:18. doi: 10.1186/s12878-016-0057-5. eCollection 2016.</citation>
    <PMID>27375850</PMID>
  </results_reference>
  <results_reference>
    <citation>Norrasethada L, Khumpoo W, Rattarittamrong E, Rattanathammethee T, Chai-Adisaksopha C, Tantiworawit A. The use of mean platelet volume for distinguishing the causes of thrombocytopenia in adult patients. Hematol Rep. 2019 Mar 29;11(1):7732. doi: 10.4081/hr.2019.7732. eCollection 2019 Feb 19.</citation>
    <PMID>30996849</PMID>
  </results_reference>
  <results_reference>
    <citation>Khan MI, Ullah I. Diagnostic importance of mean platelet volume, platelet distribution width and platelet large cell ratio as screening tool in immune thrombocytopenia. Porto Biomed J. 2020 Nov 24;5(6):e094. doi: 10.1097/j.pbj.0000000000000094. eCollection 2020 Nov-Dec.</citation>
    <PMID>33283064</PMID>
  </results_reference>
  <results_reference>
    <citation>Pogorzelska K, Krętowska A, Krawczuk-Rybak M, Sawicka-Żukowska M. Characteristics of platelet indices and their prognostic significance in selected medical condition - a systematic review. Adv Med Sci. 2020 Sep;65(2):310-315. doi: 10.1016/j.advms.2020.05.002. Epub 2020 Jun 4. Review.</citation>
    <PMID>32505856</PMID>
  </results_reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>November 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2021</study_first_posted>
  <last_update_submitted>November 7, 2021</last_update_submitted>
  <last_update_submitted_qc>November 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mahy nour Z Abed elhi,MD</investigator_full_name>
    <investigator_title>Value of the platelet indices as a prognostic factor in adult thrombocytopenic patients</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

